[ PRINT ] [ Printing FAQ ] About OncoLink Editorial Board Sponsors Help See Today's OncoTip Usage Statistics Virtual Classroom Abramson Family Cancer Research Institute "Confronting Cancer Through Art" is an exhibition by people whose lives have been touched by cancer. This week we are featuring artwork by: Jacqueline Kniewasser Pontypool, Ontario Visit the Children's Art Gallery This week's artwork was donated by a pediatric cancer patient who received treatment for cancer at The Children's Hospital of Philadelphia.

Breast Cancer: Treatment Options - News Last Revision Date: Tuesday, 30-Mar-1999 09:20:38 EST Copyright © 1994-1999, The Trustees of the University of Pennsylvania WCN News: FDA panel backs approval of Herceptin for metastatic breast cancer- The Oncologic Drugs Advisory Committee of the FDA gave its backing to Herceptin, the first monoclonal antibody for treatment of breast cancer. WCN News: Tamoxifen's preventive efficacy in breast cancer questioned - two new studies published in The Lancet call into question the efficacy of tamoxifen in the prevention of breast cancer. OncoLink@ASCO98: CAF Slightly Improves Survival for High-Risk Localized Breast Cancer Patients OncoLink@ASCO98: Raloxifene Reduces Incidence of Breast Cancer by 58-66% and May Reduce Risk of Endometrial Cancer in Postmenopausal Women OncoLink@ASCO98: Higher Doses of Paclitaxel Fail to Improve Survival Rates in Women with Metastatic Breast Cancer OncoLInk@ASCO98: Monoclonal Antibody that Binds to Breast Cancer Cells Helps Stop Cancer Spread and Shrink Tumors OncoLink@ASCO98: Older Breast Cancer Patients can Tolerate Adjuvant Therapy with Doxorubicin and Cyclophosphamide OncoLink@ASCO98: Primary Breast Cancers are Reduced by Raloxifene OncoLink@ASCO98: Standard Chemotherapy Shows Increased Toxicity for Elderly with Node-Positive Breast Cancer NCI: Breast Cancer Prevention Trial Shows Major Benefit, Some Risk - This report from NCI Breast Cancer Prevention Trial (BCPT) shows a 45 percent reduction in breast cancer incidence among the high-risk participants who took tamoxifen. OncoLink@ASCO96:Optimal Timing Of Breast Cancer Surgery Within Menstrual Cycle MSNBC: Breast cancer survival boosted- Adding radiation to standard chemotherapy greatly increases the odds of survival for women with breast cancer. MSNBC: Working toward beating cancer- Although breast cancer strikes more than 180,000 woman a year in the United States, we may be starting to win the war. WCN News: FDA committee backs expanded Taxotere use

GENERAL DISCLAIMER OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider.

For further information, consult the Editors at: editors@oncolink.upenn.edu